Microglia are glial-immune cells that are essential for the function and survival of the central nervous system. Microglia not only protect neural tissues from immunological insults, but also play a critical role in neural development and repair. However, little is known about the biology of microglia in the cochlea, the auditory portion of the inner ear. In this study, we detected TMEM119 +, CD11b +, CD45 + and Iba1+ populations of cells in the rat cochlea, particularly in Rosenthal's canal, inner sulcus and stria vascularis. Next, we isolated and enriched the population of CD11b + cells from the cochlea and immortalized these cells with the 12S E1A gene of adenovirus in a replication-incompetent retroviral vector to derive a novel microglial cell line, designated Mocha (microglia of the cochlea). The resulting Mocha cells express a number of markers consistent with microglia and respond to lipopolysaccharide (LPS) stimulation by upregulation of genes (Cox2, ICAM-1, Il6r, Ccl2, Il13Ra and Il15Ra) as well as releasing cytokines (IL-1beta, IL-12, IL-13 and RANTES). As evidence of microglial function, Mocha cells phagocytose fluorescent beads at 37°C, but not at 4°C. The expression pattern of microglial markers in Mocha cells suggests that immortalization leads to a more primitive phenotype, a common phenomenon in immortalized cell lines. In summary, Mocha cells display key characteristics of microglia and are now available as a useful model system for the study of cochlear microglial behavior, both in vitro and in vivo.
Introduction
Microglia are a unique lineage of mononuclear phagocytic cells that play an essential role in development, immunological defense and inflammatory processes in the central nervous system (review- Prinz and Priller, 2014; Cherry et al., 2014) . In development, microglia carry out synaptic pruning and remodeling (Paolicelli et al., 2011) while also secreting brain-derived neurotrophic factor and other factors that modulate synaptic plasticity (Parkhurst et al., 2013) . In adult neural tissues, microglia are the first line of immunological defense, transitioning from a surveilling state to an activated state in response to conditions of cytotoxicity and cellular damage (Nimmerjahn et al., 2005) . The multifunctional behavior of microglia is very dependent on environmental cues and tissue location as well as complex interactions with surrounding cell types (Kabba et al., 2017) . Microglia have been described in the context of the brain, spinal cord (Galatro et al., 2017) , and retina (Arroba and Valverde, 2017) , but little is known about the biology of microglial cells in the cochlea of the inner ear (O'Malley et al., 2016) , a site vulnerable to damage by aging, noise and ototoxic compounds. Very recent studies have begun to address the role of Iba1 + microglia (Okano et al., 2008) in response to noise exposure in the peripheral and central auditory system of the rat (FuentesSantamaria et al., 2017) , but much more characterization is needed. To address this gap in knowledge, we explored the possibility of harvesting and enriching microglia from the rat cochlea with the goal of immortalizing and cultivating them in culture as a novel microglial cell line.
Here, we demonstrate multiple microglial markers in the p3 rat cochlea, enrichment of CD11b + cells, followed by the establishment and characterization of a novel immortalized microglial cell line. This cell line, designated Mocha (microglia of the cochlea), was immortalized using the growth-stimulating 12S gene of adenovirus in a replication-incompetent viral vector (Cone et al., 1988) . The resulting Mocha cells express markers associated with primary microglial cells and respond to pro-inflammatory lipopolysaccharide (LPS) stimulation by alterations in gene expression and cytokine/chemokine release consistent with inflammation. In addition, Mocha cells demonstrate the capacity to phagocytose fluorescent beads at physiological temperature, a hallmark of microglial function. In summary, Mocha cells provide a unique 12S E1A-immortalized microglial cell culture model of cochlear origin for evaluation of microglial behavior and function, both in vitro and in vivo, allowing for a better understanding of inflammatory processes in the cochlea related to health and disease.
Methods

Cochlear explant culture
All animal studies were carried out with prior approval by the Institutional Animal Care and Use Committee of the University at Buffalo. The procedures for preparing rat cochlear organotypic cultures have been described previously (Ding et al., 2002 (Ding et al., , 2011 (Ding et al., , 2012 (Ding et al., , 2013 (Ding et al., , 2014 . Briefly, on postnatal day 3, rat pups were decapitated. The cochleae were then removed and placed in Hank's balanced salt solution (1 × GIBCO, 14175, Invitrogen, Carlsbad, CA). After removing the lateral wall, the whole basilar membrane containing the organ of Corti and spiral ganglion neurons were isolated, transferred onto a drop of 10 μl collagen gel matrix in a 35 mm culture dish. The collagen gel was prepared with a solution consisting of 15 μl of rat tail collagen (Type 1, BD Biosciences, 4236 Bedford, MA), 10 × basal medium eagle (BME, Sigma B9638), and 2% sodium carbonate in a 9:1:1 ratio. The collagen gel was submerged in 1.3 ml of serum-free medium consisting of 2 g bovine serum albumin (BSA, Sigma A-4919), 2 ml serum-free supplement (Sigma I-1884), 4.8 ml of 20% glucose (Sigma G-2020), 0.4 ml penicillin G (Sigma P-3414), 2 ml of 200 mM glutamine (Sigma G-6392), and 190.8 ml of 1× BME (Sigma B-1522), and the cochlear explants were then incubated for 24 h (Forma Scientific 3029, 37°C in 5% CO 2 ).
Microglia enrichment and cell culture
Rat cochleae (Charles River, Wilmington, MA) were harvested from postnatal day 3 Sprague-Dawley rats. To create the Mocha cell line, cochleae were mechanically triturated to promote a single-cell suspension. Immunomagnetic positive enrichment of cochlear-derived microglia was performed with the EasySep "Do It Yourself" Selection Kit (STEMCELL Technologies, Vancouver, BC Canada), coupled with an antibody against the microglia cell surface marker CD11b (Ab8879, Abcam, Cambridge, MA). Microglia-enriched cochlear cells were plated in 35 mm dishes in DMEM with 10% calf serum. After 48 h, cells were incubated with a replication-incompetent 12S E1A-immortalizing retrovirus (Cone et al., 1988) for two rounds of 4 h each. These cell cultures were expanded for 4 days, followed by neomycin treatment for two weeks to select for cells expressing G418 resistance associated with the E1A immortalizing vector. Mocha cells were expanded and sent to IDEXX-RADIL testing labs (Columbia, MO) for authentication and short tandem repeat (STR) marker analysis.
Immunocytochemistry
The following primary antibodies were used for immunocytochemistry of cochlear explants and Mocha cells: rabbit anti-TMEM119 (1 μg/ml, NBP2-30551, Novus Biologicals, Littleton, CO), mouse anti-CD11b (2.7 μg/ml, Ab8879, Abcam, Cambridge, MA), mouse anti-Iba (2 μg/ml, Santa Cruz Biotechnology), mouse anti-CD68 (5 μg/ml, MCA341GA, Bio-Rad, Hercules, CA), rabbit anti-CD45 (10 μg/ml, Ab10558, Abcam), mouse anti-E1A (2 μg/ml, Ab33183, Abcam), mouse anti-F4/80 (2 μg/ml, sc-377009, Santa Cruz, Santa Cruz, CA), rabbit anti-IL1-beta (5 μg/ml, Ab9722, Abcam), rabbit anti-SOX10 (1:100 dilution Abcam, Ab155279), CD40 (1:100, NB100-56127, Novus Biologicals), beta-tubulin (10 μg/ml, Sigma, St. Louis, MO). The secondary antibodies used for both cochlear explants and Mocha cells were: Dylight-488 anti-rabbit and Dylight-549 anti-mouse antibodies (5 μg/ml, Vector Laboratories, Burlingame, CA).
Cochlear explants were fixed for 2 h in 10% phosphate buffered formalin, rinsed with 0.01 M PBS and then incubated at 4°C overnight in primary antibody solution containing primary Ab, horse serum (10%), Triton X-100 (5%) and 0.01 M PBS. Following rinses with PBS, the tissues were then incubated at 4°C overnight in a secondary antibody solution containing secondary Ab, horse serum (10%), Triton X-100 (5%) and 0.01 M PBS. Following a rinse in 0.01 M PBS, the tissues were incubated with TO-PRO-3 (T3605 Life Technologies, Grand Island, NY) to label cell nuclei just prior to visualization. Tissues were mounted on glass slides in glycerin, coverslipped, and viewed with a confocal microscope (Zeiss LSM-510) with appropriate fluorescence filters.
Mocha cell cultures were grown on glass coverslips and stained for a variety of microglial and non-microglial markers. Briefly, cells were fixed on coverslips with either 4% paraformaldehyde or cytospin solution (72% isopropyl alcohol, 19% acetone, 7.6% glycerol) for 10 min and stored in PBS buffer (PBS; 0.15 M NaCl, 8 mM Na2HPO4, 2.6 mM KCl, 1.5 mM KH2PO4) at 4°C until staining. Cells on coverslips were permeabilized with PBS + 0.05% Tween-20 for 5 min, followed by incubation in primary antibody or isotype control antibody (negative control) for 1 h. Cells were rinsed in PBS, and incubated in fluorescent secondary antibody for 45 min at room temperature with anti-rabbit Dylight 488 or anti-mouse Dylight 555 (Vector Labs, Burlingame, CA) at 5 μg/ml in PBS with 0.05% Tween-20. Coverslips were mounted on slides with Vectashield mounting medium (Vector Labs) containing DAPI counterstain. Digital images were captured with a SONY ICX 285AL SPOT camera (Diagnostic Instruments, Sterling Heights, MI).
ELISA analysis
In order to determine the secretion of cytokines and chemokines by resting and LPS-stimulated Mocha cells, we utilized a Multi-Analyte ELISArray from Qiagen (Germantown, MD; Cat no: MER-004A) to evaluate the presence of 12 cytokines and chemokines: IL1α, IL1β, IL2, IL4, IL5, IL10, IL12, IL13, IFN-γ, TNF-α, GM-CSF, and RANTES. Twentyfour hour conditioned media from Mocha cells and R28 cells (treated/ not treated with 2 μg/ml LPS) were collected, concentrated from 7 ml to 0.7 ml using Amicon Ultra centrifugal filters (3000 NMWL) at 3000g for 50 min. Non-conditioned medium was used as a negative control.
Gene array
We designed a custom PCR gene array (SA Biosciences, Germantown, MD) to investigate expression of genes anticipated to be present/absent in microglia. In addition, the array contained primers for housekeeping genes (LDHA, ACTB, B2M, HPRT1 and RPLP1) to facilitate normalization, genomic DNA primer to detect genomic DNA contamination, transcription controls and positive PCR controls to test the efficiency of cDNA conversion as well as the PCR reaction. The PCR reaction was carried out using SYBR Green fluorescence (SABiosciences) technology measured by a Bio-Rad MyiQ Single Color Real Time PCR System. Cycle threshold (CT) values were determined for each gene of the array.
Phagocytosis
As a functional assay to measure phagocytosis, we added a 1:1000 dilution of 1.0 μm (non-opsinized) fluorescent beads comprised of carboxylate-modified polystyrene (excitation 470 nm; emission 505 nm) (Sigma, St. Louis, MO) to cultures of Mocha cells or R28 cells in standard culture medium. Cells were incubated with beads for up to 2 h at 4°C and 37°C and rinsed with PBS. We captured still images using a Spot camera (Spot Imaging Solutions, Sterling MI). Multifocal images of ingested beads were obtained after incubating Mocha cells with fluorescent polystyrene beads for 2 h, followed by a brief incubation with 10 μg/ml Hoechst 33342 nuclear stain (Invitrogen, Eugene Oregon). A Zeiss Axio Observer microscope (Carl Zeiss Microscopy, Peabody, MA) equipped with a Zeiss Apotome structured-illumination system and deconvolution software were used for obtaining high-resolution optical slices for 3-D reconstruction of fluorescent beads within cells.
Results
Microglial markers expressed in rat cochlea
We examined p3 rat cochlea for immunoreactivity to microglial markers CD11b, Iba1 and TMEM119. We chose p3 rat cochlea G.M. Seigel et al. Molecular and Cellular Neuroscience 85 (2017) 202-210 specifically to match the tissue from which microglial cells were harvested for immortalization. In Fig. 1A , CD11b immunolabeling was seen predominantly in Rosenthal's canal, with somewhat fewer CD11b + cells in the limbus, inner sulcus and organ of Corti. In Fig. 1B , we observed TMEM119, a highly specific microglial marker (Satoh et al., 2016; Bennett et al., 2016) on numerous cells including the peripheral axon of spiral ganglion neurons, the limbus region and the organ of Corti. TMEM119 + and CD11b + cells were also seen in the stria Fig. 1. (continued) G.M. Seigel et al. Molecular and Cellular Neuroscience 85 (2017) 202-210 vascularis (Fig. 1C ). Double immunolabeling with TMEM119 and Iba1 revealed co-localization of immunopositive cells in Rosenthal's canal and inner sulcus (Fig. 1D) . Based on microglia immunoreactivity and immune-colocalization in the cochlea, we utilized CD11b, a cell surface marker of microglia, to perform cell separation and enrichment of CD11b-positive cells in order to develop a novel cell line derived from cochlear microglia.
Microglial genes expressed by Mocha cells
Once the CD11b-enriched cells from cochlea were immortalized with the 12SE1A gene of adenovirus and survived G418 selection, we designed a custom gene array to determine the expression of genes typically expressed by microglia. Table 1 lists these genes that were expressed above background levels, after normalization with housekeeping genes, including TMEM119, IGF-1, CD68, TNFR1, CD54 (ICAM-1), CD40, CD74, Ccl2, B7-1, IFNgR, Sgpp1, IL1R1, IL13RA1, IL15RA, CCR5, Cox2, P2Y12, Il6R and MAP2. The elevated expression of these microglia-associated genes provides evidence of their microglia-like phenotype.
Immunoreactivity of microglial markers in the Mocha cell line
To validate gene array results with expression at the protein level, we carried out immunocytochemical analysis of Mocha cells to detect microglial marker immunoreactivity on a cell-by-cell basis. Fig. 2 shows that Mocha cells were immunoreactive to a number of microglia markers, including CD68, Sox10, CD11b, CD40, Iba1, TMEM119, IL-1beta, CD45 and F4/80, as well as the 12SE1A protein used for immortalization. Mocha cells were immunonegative, as anticipated, for neuronal beta-tubulin.
LPS activates Mocha cells and stimulates secretion of cytokines
LPS is an activator of microglial cells, with known effects on gene expression and cellular activity. We treated Mocha cells with LPS for 24 h to elicit a response, both in terms of gene expression and secretion of specific cytokines and chemokines. In Table 2 , gene array analysis of Mocha cells revealed several genes responded to LPS treatment by increased expression levels, particularly Ccl2 (30-fold), Cox2 (2.9-fold), CD54 (3.3-fold) and IL6R (2.4-fold). In contrast, MAP2 decreased to 0.587 of the pre-LPS level.
We treated Mocha cells and R28 cells (as a control) with LPS for 24 h to elicit the secretion of specific cytokines and chemokines expressed by microglia, but presumably not by R28 retinal precursor cells. In Fig. 3 , ELISA analysis of concentrated conditioned medium from Mocha cells showed statistically significant LPS enhanced secretion of IL1-beta, IL-12, IL-13 and RANTES. In contrast, LPS-treatment of R28 retinal precursor cells did not result in detectable secretion of IL1-beta, Mean values are presented in pg/ml, ± standard deviation. ND -not detected * P < 0.05, ** P < 0.01, *** P < 0.001. G.M. Seigel et al. Molecular and Cellular Neuroscience 85 (2017) 202-210 IL-2 or IL-13, while a low level of RANTES secreted under control conditions diminished upon LPS treatment (not shown).
Mocha cells phagocytose fluorescent beads
Phagocytosis is a hallmark of microglial cell behavior as scavengers of microorganisms and debris. We designed an experiment to evaluate phagocytosis by Mocha cells and R28 cells with the use of 1.0 μm fluorescent carboxylate-modified polystyrene latex beads. In the first experiment, Mocha cells and R28 cells were grown on glass coverslips and incubated with fluorescent beads at 4°C and 37°C, respectively. We used non-opsonized beads so as not to extrinsically promote cellbead interactions. After 1 h, we observed many fluorescent beads associated with Mocha cells at 37°C (Fig. 4B) , with very few at 4°C, presumably due to decreased metabolic activity at the lower temperature (Fig. 4A) . In contrast, R28 cells did not appear to associate with the beads at either temperature ( Fig. 4C and D) . Although we could see beads closely associated with Mocha cells, it was not entirely clear at this magnification whether the beads were actually internalized. In order to confirm internalization, we incubated Mocha cells with fluorescent beads at 37°C for 2 h and viewed them under light microscopy ( Fig. 4E) and then under high-resolution confocal microscopy with deconvolution 3-D analysis. In Fig. 4F -G, fluorescent beads are clearly internalized by Mocha cells, as seen in three different axes of the same cell, with the nucleus as a reference point.
Mocha cell line authentication
A frozen vial of Mocha cells at passage 5 was sent to IDEXX-RADIL for cell line authentication and short tandem repeat (STR) marker analysis, as shown in Fig. 5 . The Mocha cell line was confirmed to be of rat cell origin without other contaminating cell types. STR marker analysis is presented for future comparison and verification purposes.
Discussion
In this study, we examined resident microglial cells present within the P3 rat cochlea, with potential implications for inflammatory processes within the cochlea related to development, damage and repair. Little is known about how the cellular debris from developing or damaged cochlea is removed. Because intense noise exposure, ototoxic drugs, aging and other ototraumatic events lead to necrotic and apoptotic cell death and subsequent release of inflammatory molecules and cellular debris that need to be phagocytized and removed, cochlear microglia likely serve as "first responders" in cases of chronic and acute cochlear pathology. Indeed, after an intense noise exposure that caused massive damage to the cochlea, we observed intense microglia immunolabeling around the degenerating auditory nerve fibers that project from the soma of spiral ganglion neurons in the cochlea to the cochlear nucleus in the brainstem (Baizer et al., 2015) . Microglia upregulation and neural degeneration persisted for up to 9 months following the initial insult. As further evidence for trauma-mediated microglial activation in the cochlea, an increase in Iba1 + cells colocalized with TNF-alpha and IL1-beta has been reported in the spiral ganglion of noise-exposed rats (Fuentes-Santamaria et al., 2017) . These findings support the hypothesis that microglia may be an important source of pro-inflammatory cytokines, such as IL-1beta, IL-6 and TNFalpha produced in response to noise damage in the cochlea (Fujioka et al., 2006) . From CD11b + enriched cells of the cochlea, we have developed a unique microglial precursor cell line called Mocha (microglia of the cochlea). Mocha cells express a number of known microglial markers, including TMEM119, Iba1, CD45, CD68 and Cox2. Mocha cells also express the 12S E1A immortalizing gene of adenovirus, as well as an G.M. Seigel et al. Molecular and Cellular Neuroscience 85 (2017) 202-210 accompanying neomycin (G418) resistance gene (Cone et al., 1988) . We have demonstrated physiological responses of Mocha cells consistent with microglial cell behavior. LPS stimulation of Mocha cells leads to increased expression levels of Cox2, CD54 (ICAM-1), Il6r, Ccl2, Il13Ra and Il15Ra, as well as increased secretion of IL1-beta, IL-12, IL-13 and RANTES; these cytokines and chemokines involved in inflammation were not secreted by R28 retinal cells in response to LPS treatment. These results suggest future studies in which these microglia-secreted cytokines and chemokines could be applied to the cochlea in vivo or in vivo to determine their functional and histological consequences. Mocha cells are able to phagocytose fluorescent beads, a cellular function attributed to microglia. Future in vitro studies could be carried out to determine if Mocha cells ingest the cellular debris released by damaged hair cells, neurons and supporting cells in cochlear organotypic cultures. Phagocytosis is more pronounced at 37°C compared with 4°C, an indication of increased cellular activity at physiological temperature.
It is currently unclear whether microglia derived from different species or different portions of the central nervous system share identical or divergent properties. Mocha cells are different from existing microglial cell lines, such as the mouse brain-derived SIM-A9 (Nagamoto-Combs et al., 2014), N9 (Righi et al., 1989) , and BV2 cell lines (Blasi et al., 1990) as well as the human HMO6 cell line (Nagai et al., 2001) . Mocha cells are derived from the rat cochlea and are immortalized with the 12S E1A gene using a replication-incompetent retroviral vector, which allows for in vivo studies without the confounding issue of host retroviral infection. The 12S E1A gene differs from the oncogenes used to immortalize the brain-derived murine microglial cell lines in that the 12S E1A gene is growth-promoting, but not tumorigenic by itself (Cone et al., 1988) . There are some differences in gene expression patterns between the microglial cell lines, but all are phagocytic and respond to activation by secretion of cytokines (Stansley et al., 2012) .
The Mocha microglial cell line has unique properties, due in part to the expression of 12S E1A, not found in other microglial cell lines. Immortalization is known to affect growth rate as well as expression of some genes associated with mature cell types. Proliferation can lead to a precursor-like state, which may account for the presence of MAP2, a neuronal protein that can be expressed by microglia under neuronal differentiating conditions as a function of plasticity (Matsuda et al., 2008) . Interestingly, MAP2 was downregulated in Mocha cells upon LPS activation, as shown in Table 2 .
There were some minor differences in expression of microglial markers CD11b and IL-1beta across our detection platforms. Mocha cells displayed immunoreactivity to CD11b and IL-1beta and also secreted IL1-beta but did not display these markers in the gene array. This may be explained by differences in the specific probe used for the gene array vs. the epitope used for immunocytochemistry and ELISA, or the possibility of regulation of gene expression at the protein level, due in part to growth stimulation by expression of 12S E1A. TMEM119, a recently identified and highly specific marker for microglia (Satoh et al., 2016; Bennett et al., 2016) was expressed at significant levels in all platforms, as was Iba1. As with most other immortalized cell lines, Mocha cells are not a perfect substitute for primary cells, but represent a powerful tool for drug screening, gene expression analysis and studies of microglial cell behavior. To place this in context, R28, a sister cell line to Mocha, is a rat retinal precursor cell line established over 20 years ago using the same 12S E1A immortalization technique (Seigel, 1996) . R28 cells, like Mocha cells, do not express all markers of the mature cell type (Seigel et al., 2004) , but can respond to some conditions that promote differentiation (Sperling et al., 2012) . R28 cells have been utilized in hundreds of studies, both in vitro and in vivo as a G.M. Seigel et al. Molecular and Cellular Neuroscience 85 (2017) 202-210 model for cytotoxicity (Patil et al., 2009) , differentiation (Sperling et al., 2012) , transplantation (Seigel et al., 1998) and retinal cell behavior (Uddin et al., 2016) . We anticipate that Mocha cells will show similar utility in studies relating to the inner ear as an immortalized cell line. Factors secreted from Mocha cells in response to ototoxic drugs such as cisplatin could be evaluated to determine if these secreted factors are themselves toxic or promote repair, differentiation or survival. Drugs screens could be conducted with Mocha cells to identify compounds that suppress or promote proliferation or activation. Coculture studies with other cochlear cell types could aid in elucidating the role of microglial cells in development and neuroprotection in the inner ear. Microglia appear to be involved in synaptic remodeling and factors secreted by microglia could be used to determine how they affect the afferent and efferent synapses expressed in the cochlea. These studies will lead to a better understanding of signaling pathways involved in microglial function that can aid in the development of targeted interventions for the inner ear to maintain and restore auditory function.
